CLINICAL_TRIALS
trial_result
· 2019-05-10
Clinical Trial Update: Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML) [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial of plerixafor and clofarabine as frontline therapy in elderly AML patients; trial terminated with posted results in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myelogenous Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-05-10